MG
RMD icon

Michael Gelband’s ResMed RMD Stock Holding History

Michael Gelband’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,706
Closed -$2.38M – 1984
2025
Q3 		$2.38M Buy
+8,706
New +$2.38M 0.02% 679
2024
Q1 		– Sell
-84,713
Closed -$14.6M – 1896
2023
Q4 		$14.6M Buy
84,713
+65,406
+339% +$10M 0.1% 150
2023
Q3 		$2.85M Sell
19,307
-65,863
-77% -$11.9M 0.03% 558
2023
Q2 		$18.6M Buy
85,170
+53,631
+170% +$12M 0.15% 118
2023
Q1 		$6.91M Sell
31,539
-14,887
-32% -$3.23M 0.06% 405
2022
Q4 		$9.66M Buy
+46,426
New +$10.2M 0.14% 175
2022
Q1 		– Sell
-20,273
Closed -$5.28M – 2603
2021
Q4 		$5.28M Buy
20,273
+12,391
+157% +$3.22M 0.05% 416
2021
Q3 		$2.08M Buy
7,882
+5,849
+288% +$1.6M 0.03% 704
2021
Q2 		$501K Sell
2,033
-779
-28% -$164K 0.01% 1419
2021
Q1 		$546K Buy
2,812
+1,534
+120% +$308K 0.01% 1286
2020
Q4 		$272K Buy
+1,278
New +$255K ﹤0.01% 1591
2020
Q2 		– Sell
-4,496
Closed -$662K – 1989
2020
Q1 		$662K Sell
4,496
-7,256
-62% -$1.16M 0.04% 406
2019
Q4 		$1.82M Buy
11,752
+6,836
+139% +$985K 0.03% 369
2019
Q3 		$664K Buy
+4,916
New +$644K 0.02% 535

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Michael Gelband's RMD Position: Q4 2025 in Review

Michael Gelband sold out of ResMed (RMD) in Q4 2025, closing a stake of 8,706 shares — an estimated $2.38M sold.

Michael Gelband first reported a position in RMD in Q3 2019 and held it in 14 quarters. The position peaked at $18.6M in Q2 2023. 947 funds tracked by Wall St. Rank hold RMD as of Q4 2025.

  • Michael Gelband reported no remaining ResMed position as of Q4 2025 after selling out during the quarter.
  • Michael Gelband sold 8,706 ResMed shares in Q4 2025, an estimated $2.38M.
  • Michael Gelband first reported a position in ResMed in Q3 2019 and held it in 14 quarters.
  • Michael Gelband's ResMed position peaked at $18.6M in Q2 2023.
  • 947 funds tracked by Wall St. Rank held ResMed as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.